Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Essence (BIOE) Net Income towards Common Stockholders (2020 - 2025)

Bio Essence has reported Net Income towards Common Stockholders over the past 6 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $896197.0, up 248.82%, while the annual FY2025 figure was $896197.0, 841.72% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $1.0 million at Bio Essence, up from $12998.0 in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $1.0 million in Q4 2025 and troughed at -$633126.0 in Q3 2023.
  • A 5-year average of $146886.9 and a median of $171514.5 in 2022 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 210.82% in 2022 and later tumbled 417.78% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at $90634.0 in 2021, then surged by 135.16% to $213131.0 in 2022, then skyrocketed by 192.82% to $624087.0 in 2023, then tumbled by 119.36% to -$120827.0 in 2024, then soared by 951.7% to $1.0 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for BIOE at $1.0 million in Q4 2025, $12998.0 in Q3 2025, and $59864.0 in Q2 2025.